Below are various articles about the popularity of homeopathy in the early 2000s
21/11/2005 Large 6 year study of 6500 patients shows positive effects for homeopathy
In one of the largest studies ever carried out over 70% of the 6500 patients involved reported significant benefits from homeopathic treatment. The results come from a 6 year study of 6500 consecutive patients seen in the outpatient clinic of the Bristol Homeopathic Hospital in the UK, a UK National Health Service Hospital. The study is reported in the international peer-reviewed Journal of Alternative and Complementary Medicine.
Patients with a wide range of conditions such as eczema, asthma, migraine, irritable bowel syndrome, menopause, arthritis, depression and chronic fatigue syndrome were included in the study, all patients having been referred by their General Practitioner or a hospital specialist after unsuccessful conventional treatment.
While the debate continues over how homeopathy’s remedies work patients continue to receive benefit from them. Such a study as this is incontrovertible evidence that something much more than just a placebo effect is going on with homeopathy and that for patients its results that count.
Homeopathic Treatment for Chronic Disease: A 6-Year, University-Hospital Outpatient Observational Study
David S. Spence, Elizabeth A. Thompson, S.J. Barron
Journal of Alternative and Complementary Medicine: Oct 2005, Vol. 11, No. 5: 793-798.
Available online at: http://www.liebertonline.com/toc/acm/11/5
20/11/2005 Homeopathy Alive and Kicking!
Despite predictions of the ‘end of homeopathy’ by the Lancet’s editor in August, based on a highly questionable piece of statistical work, homeopathy is continuing to show the resilience it has always had to prejudice. Evidence for this comes in the latest edition of The Journal of Alternative and Complementary Medicine (Volume 11, Number 5, 2005,) which its editor has chosen to dedicate almost completely to homeopathy, partly to celebrate the 250th anniversary of Samuel Hahnemann’s birthday and partly as a repost to the Lancet’s attack and the refusal of its editor to publish a number of letters and articles.
The Editor of the Lancet has done the reputation of his journal huge damage in descending to the level of what can only be described as tabloid journalism. He has allowed his own personal prejudices to damage its academic and scientific credibility. He has added further insult to that injury in refusing to publish a number of reasoned letters of response and at least one article contained in this issue in JACM.
Readers of this news item are invited to read the the latest issue of JACM themselves and make their own minds up. The editorial is essential reading. The publishers of have made the whole issue available free. It can be accessed at http://www.liebertonline.com/toc/acm/11/5
16/11/05 European Homeopathic Medicines Harmonisation Badly Needed
As the European Heads of (Medicines) Agencies Homeopathic Medicinal Products Working Group (HMPWG) meets in Brighton under the UK’s EU Presidency on 16 November ECCH wishes to express its extreme concern over the way that some individual Member States of the EU are separately implementing the revised Pharmaceutical Directives in an haphazard and uncoordinated manner with regards to homeopathic medicinal products.
ECCH is particularly concerned at the way officials in some Member States are dealing with homeopathic nosodes. Nosodes are an essential category of remedy that all homeopathic practitioners use in their treatment of chronic disease in patients. They have been used for the past two hundred years with no evidence whatsoever of any risk to patients yet in some countries medicines agencies have introduced, or are planning to introduce, regulatory requirements that will result in the eventual non-availability of them to practitioners. As with all homeopathic medicinal products the standard potentization process together with Good Manufacturing Practice renders all homeopathic medicinal products safe for human and animal treatment.
In the Spring of this year the HMPWG published a consultation document POINTS TO CONSIDER ON SAFETY OF HOMEOPATHIC MEDICINAL PRODUCTS FOR HUMAN AND VETERINARY USE FROM BIOLOGICAL ORIGIN to which ECCH and other interested parties responded. We are sure that this document will be under consideration at the current meeting of the HMPWG and we call on all EU Member States Medicines Agencies to await the outcome of these deliberations which should facilitate the continued availability of these essential medicines through reasonable legislation.
In response to the situation described above ECCH has revised its own pharmacy report at its recent Council meeting in Athens and attaches it here for reference. The report has been sent to all EU Medicines Agencies ahead of the above-mentioned meeting in Brighton. A pdf copy can be obtained by sending an email to: firstname.lastname@example.org
12/10/2005 Royal London Homeopathic Hospital Reopens
Europe’s largest public hospital using homeopathy and other complementary health care therapies was officially re-opened on 12 October 2005 by HRH The Prince of Wales. The hospital, which has stood on the same site since 1840, has undergone a £20M programme of refurbishment and is now set to play its full role in the growing provision of CAM therapies in the UK National Health Service. Part of the original hospital has been taken up by the neighboring Great Ormond Street Childrens’ Hospital and this should encourage a program of integration of both conventional and complementary health services that will enhance the health care of each child.
In his speech the Prince of Wales acknowledged the important role that the hospital has played up until now in developing the programme of an integrated health agenda of which he has been such a long-term advocate and he looked forward to an even greater contribution from the hospital in its newly refurbished form. The opening event was attended by Dr Xiaorui Zhang, Coordinator, Traditional Medicine, World Health Organization. The Hospital’s clinical director Dr Peter Fisher said that rather than the refurbishment being a dream come true it has set the platform for a much bigger dream that he has to come true in the future.
6/10/2005 Independent Report Recommends Serious Consideration of Greater Integration of Homeopathy and 4 other CAM Therapies into UK Health Service: The Smallwood Report
Thursday 6 October saw the publication of The Role of Complementary and Alternative Medicine in the NHS, a report led by Christopher Smallwood, former chief economic advisor to Barclays PLC. The report was commissioned by HRH The Prince of Wales and investigates the contribution that complementary and alternative medicines could potentially make to the delivery of healthcare in the UK and focuses on the ‘big five’; osteopathy; chiropractic; acupuncture; homeopathy and herbal medicine.
Rather than focusing just on the actual costs to the NHS of introducing the services the report predicts that there could be wider economic benefits of introducing the practices into mainstream NHS healthcare delivery.